Afiat Berbudi

1.9k total citations · 2 hit papers
50 papers, 1.3k citations indexed

About

Afiat Berbudi is a scholar working on Plant Science, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Afiat Berbudi has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Plant Science, 9 papers in Infectious Diseases and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Afiat Berbudi's work include Computational Drug Discovery Methods (8 papers), Parasitic Diseases Research and Treatment (6 papers) and Parasites and Host Interactions (6 papers). Afiat Berbudi is often cited by papers focused on Computational Drug Discovery Methods (8 papers), Parasitic Diseases Research and Treatment (6 papers) and Parasites and Host Interactions (6 papers). Afiat Berbudi collaborates with scholars based in Indonesia, Germany and United Kingdom. Afiat Berbudi's co-authors include Adi Imam Tjahjadi, Nofri Rahmadika, Rovina Ruslami, Jesuthas Ajendra, Achim Hoerauf, Marc P. Hübner, Anas Subarnas, Laura E. Layland, Fabian Gondorf and David Schmidt and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS Pathogens and International Journal for Parasitology.

In The Last Decade

Afiat Berbudi

41 papers receiving 1.3k citations

Hit Papers

Type 2 Diabetes and its I... 2019 2026 2021 2023 2019 2025 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Type 2 Diabetes and its Impact on the Immune System
    2019 753 citations Afiat Berbudi, Adi Imam Tjahjadi et al. profile →
  2. Interplay Between Insulin Resistance and Immune Dysregulation in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions
    2025 29 citations Afiat Berbudi, Adi Imam Tjahjadi et al. ImmunoTargets and Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Afiat Berbudi Indonesia 12 317 249 223 213 145 50 1.3k
Kurosh Kalantar Iran 16 125 0.4× 205 0.8× 130 0.6× 219 1.0× 249 1.7× 61 1.1k
Benjaluck Phonrat Thailand 19 371 1.2× 460 1.8× 160 0.7× 215 1.0× 88 0.6× 90 1.5k
David T. Bolick United States 29 447 1.4× 165 0.7× 96 0.4× 807 3.8× 309 2.1× 43 1.9k
Hongwei Zhang China 24 191 0.6× 300 1.2× 44 0.2× 383 1.8× 144 1.0× 116 1.7k
Tohru Sakai Japan 26 142 0.4× 298 1.2× 262 1.2× 551 2.6× 392 2.7× 133 2.2k
Adi Imam Tjahjadi Indonesia 4 207 0.7× 190 0.8× 172 0.8× 124 0.6× 72 0.5× 7 798
Sofia Reddel Italy 21 313 1.0× 508 2.0× 71 0.3× 1.3k 6.2× 112 0.8× 40 2.2k
Shabnam Shahrokh Iran 22 262 0.8× 258 1.0× 38 0.2× 529 2.5× 163 1.1× 93 1.2k
Iosif Kelesidis United States 19 167 0.5× 977 3.9× 155 0.7× 373 1.8× 149 1.0× 36 2.8k
Yongjun Li China 17 331 1.0× 528 2.1× 89 0.4× 517 2.4× 59 0.4× 41 1.4k

Countries citing papers authored by Afiat Berbudi

Since Specialization
Citations

This map shows the geographic impact of Afiat Berbudi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afiat Berbudi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afiat Berbudi more than expected).

Fields of papers citing papers by Afiat Berbudi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afiat Berbudi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afiat Berbudi. The network helps show where Afiat Berbudi may publish in the future.

Co-authorship network of co-authors of Afiat Berbudi

This figure shows the co-authorship network connecting the top 25 collaborators of Afiat Berbudi. A scholar is included among the top collaborators of Afiat Berbudi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afiat Berbudi. Afiat Berbudi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fauziah, Nisa, et al.. (2025). Targeting T-Cell Activation for Malaria Immunotherapy: Scoping Review. Pathogens. 14(1). 71–71. 1 indexed citations
2.
Berbudi, Afiat, et al.. (2025). Interplay Between Insulin Resistance and Immune Dysregulation in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions. ImmunoTargets and Therapy. Volume 14. 359–382. 29 indexed citations breakdown →
3.
Agustian, Dwi, Qorinah Estiningtyas Sakilah Adnani, Muhammad Hasan Bashari, et al.. (2024). Academic Health System Framework for Health Services Transformation: A Perspective View from West Java, Indonesia. Advances in Medical Education and Practice. Volume 15. 957–969.
4.
5.
6.
Subarnas, Anas, et al.. (2023). MOLECULAR DOCKING STUDY AND PHARMACOPHORE MODELLING OF URSOLIC ACID AS AN ANTIMALARIAL USING STRUCTURE-BASED DRUG DESIGN METHOD. International Journal of Applied Pharmaceutics. 206–211. 2 indexed citations
7.
Berbudi, Afiat, et al.. (2023). Evaluation of Experimental Cerebral Malaria of Curcumin and Kaempferol in Plasmodium berghei ANKA-Infected Mice. Pharmacognosy Journal. 14(6s). 905–911. 4 indexed citations
8.
Subarnas, Anas, et al.. (2023). The combination of apigenin and ursolic acid reduces the severity of cerebral malaria in Plasmodium berghei ANKA-infected Swiss Webster mice. Journal of Applied Pharmaceutical Science. 2 indexed citations
9.
Berbudi, Afiat, et al.. (2022). Antimalaria Activities of Several Active Compounds from Medicinal Plants. Pharmacognosy Journal. 14(1). 245–252. 8 indexed citations
10.
11.
Fauziah, Nisa, et al.. (2022). Oral Administration of Piperine as Curative and Prophylaxis Reduces Parasitaemia in Plasmodium berghei ANKA-Infected Mice. Journal of Tropical Medicine. 2022. 1–11. 8 indexed citations
12.
Berbudi, Afiat, et al.. (2021). Performance of CO1 and ITS2 nested PCR in molecular identification of ordinary scabies (Sarcoptes scabiei var. hominis). SHILAP Revista de lepidopterología. 26(4). 183–183.
13.
14.
Fauziah, Nisa, et al.. (2021). The Potential use of a Curcumin-Piperine Combination as an Antimalarial Agent: A Systematic Review. Journal of Tropical Medicine. 2021. 1–15. 16 indexed citations
15.
Berbudi, Afiat, et al.. (2021). Antimalarial activity of curcumin and kaempferol using structure-based drug design method. Journal Of Advanced Pharmacy Education And Research. 11(4). 86–90. 11 indexed citations
16.
Ekawardhani, Savira & Afiat Berbudi. (2020). The Role of Curcumin as An Antimalarial Agent. Systematic Reviews in Pharmacy. 11(7). 18–25. 7 indexed citations
17.
Subarnas, Anas, et al.. (2018). REVIEW: AKTIVITAS IMMUNOMODULATOR TANAMAN SAMBILOTO (Andrographis paniculata Nees). 16(3). 16–21. 4 indexed citations
18.
Ajendra, Jesuthas, Katrin Gentil, Afiat Berbudi, et al.. (2018). IL-6 is required for protective immune responses against early filarial infection. International Journal for Parasitology. 48(12). 925–935. 18 indexed citations
19.
Ajendra, Jesuthas, Afiat Berbudi, Achim Hoerauf, & Marc P. Hübner. (2016). Combination of worm antigen and proinsulin prevents type 1 diabetes in NOD mice after the onset of insulitis. Clinical Immunology. 164. 119–122. 18 indexed citations
20.
Gondorf, Fabian, Afiat Berbudi, Jesuthas Ajendra, et al.. (2015). Chronic Filarial Infection Provides Protection against Bacterial Sepsis by Functionally Reprogramming Macrophages. PLoS Pathogens. 11(1). e1004616–e1004616. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kurosh Kalantar Breakdown of academic impact, for papers by Benjaluck Phonrat Breakdown of academic impact, for papers by David T. Bolick Breakdown of academic impact, for papers by Hongwei Zhang Breakdown of academic impact, for papers by Tohru Sakai Breakdown of academic impact, for papers by Adi Imam Tjahjadi Breakdown of academic impact, for papers by Sofia Reddel Breakdown of academic impact, for papers by Shabnam Shahrokh Breakdown of academic impact, for papers by Iosif Kelesidis Breakdown of academic impact, for papers by Yongjun Li
Rankless by CCL
2026